v3 Template
M

Medivir

Pharmaceuticals/Healthcare ~220 employees
Founded
--
Employees (Est.)
~220
11 leaders known
Total Funding
$40.0M
Funding Rounds
2
Last Funding
2024-01-26

About Medivir

Medivir is a pharmaceutical company dedicated to developing innovative treatments for cancer, focusing on cancers with high unmet medical needs to provide benefits to patients with limited treatment options.

Products & Services

Fostroxacitabine bralpamide (fostrox):A nucleotide DNA polymerase inhibitor (oral) for cancer treatment.
Remetinostat:A project available for licensing, focused on cancer treatment.
Xerclear(r):A product developed through partnerships, specifics not detailed in content.

Specialties

Cancer treatment development Innovative pharmaceutical solutions Collaborative partnerships in drug development

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Directed Share Issue
T: -
FT: Directed Share Issue 		A: 20000000
MR: -
FA: approximately SEK 20 million
FAN: 20000000 		D: 2024-01-26
FD: 2024-01-26 		1 investors
2 RT: Directed Share Issue
T: -
FT: Directed Share Issue 		A: 20000000
MR: -
FA: approx. SEK 20 million
FAN: 20000000 		D: 2024-01-22
FD: 2024-01-22 		1 investors
Directed Share Issue Latest
2024-01-26
$20.0M
1 investor (Pro only)
Directed Share Issue 2024-01-22
$20.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

U

Uli Hacksell

Member of the Board since 2018, Chairman of the Board since 2021. Former CEO of Medivir AB

L

Lennart Hansson

Member of the Board since 2018

A

Angelica Loskog

Member of the Board

Y

Yilmaz Mahshid

Member of the Board

A

Anna Törner

Member of the Board since 2024

B

Bengt Westermark

Member of the Board

View 8 more team members with Pro

Unlock Full Team Directory

Recent News

Medivir Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Pharmaceuticals/Healthcare
Company Size
~220 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro